Skip to main content
RecallFDAfda-F-1133-2013CONTAMINATION

Tausi Brand Salted Black Beans. Net Weight 180g (6.34 oz). Distributed by: V8 Commercial Co., Inc. San Juan, Metro Manila. Product of...

Category
Units Affected
247
Recall Date
January 18, 2013
Issuing Agency
Hazard
Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1133-2013.

This recall has been initiated due to suspected but, as of the writing of this letter (1/17/2013), unconfirmed Clostridium botulinum (C. botulinum) contamination.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1133-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Phil-am Trading, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1133-2013.

Phil-Am Trading, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Phil-am Trading, Inc. Recall FAQ

Phil-am Trading, Inc. is the subject of a food safety report: Tausi Brand Salted Black Beans. Net Weight 180g (6.34 oz). Distributed by: V8 Commercial Co., Inc. San Juan, Metro Manila. Product of.... The notice was published on January 18, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 247 units are potentially affected.